5 Best Diagnostics and Research Stocks to Buy According to Analysts

Page 1 of 5

In this article, we will list the 5 Best Diagnostics and Research Stocks to Buy According to Analysts. Please visit 10 Best Diagnostics and Research Stocks to Buy According to Analysts if you’d like to see the extended list and the methodology behind it.

5. IQVIA Holdings Inc. (NYSE:IQV)

Number of Hedge Fund Holders: 69

IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 best diagnostics and research stocks to buy according to analysts.

On March 9, 2026, TD Cowen upgraded its rating on IQVIA Holdings Inc. (NYSE:IQV) from Hold to Buy. Along with the rating upgrade, the firm also raised its price target on the stock from $174 to $213. The company is anticipated to remain resilient against AI-driven revenue headwinds, according to TD Cowen analysts. It further noted that AI could potentially reduce drug trial costs by 10% to 15%, but these savings are expected to be further reinvested into research activity. Following a 24% share price decline since February, TD Cowen sees an attractive risk-reward opportunity.

5 Best Diagnostics and Research Stocks to Buy According to Analysts

Prior to this, in an unrelated event, Barclays also upgraded IQVIA Holdings Inc. (NYSE:IQV)’s rating from Equal Weight to Overweight, while maintaining a price target of $210. The firm’s analyst anticipates an upside for the stock, projecting higher valuations and financial estimates. It added in a research note that the consistency in its execution justifies a premium market valuation for IQVIA Holdings Inc. (NYSE:IQV).

Founded in 1982, IQVIA Holdings Inc. (NYSE:IQV) is a global leader in clinical research and health data, headquartered in North Carolina.

Page 1 of 5